COVID-19: a Global Health Perspective

The Broad Global Health Initiative brings together local and international Broad Insitute collaborators to share their experiences of COVID-19 with the aim of spotlighting the impact of the pandemic around the world. Speakers provide perspectives on their communities’ response to the outbreak, discuss implications for their research or practice, and share lessons learned.

Carlos Aguilar-Salinas, M.D., Ph.D. Director of Nutrition, National Institute of Medical Sciences and Nutrition Salvador Zubirán Mexico City, Mexico Teresa Tusié-Luna, M.D., Ph.D. Head of Molecular Biology and Genomic Medicine, National Institute of Medical Sciences and Nutrition Salvador Zubirán & National Autonomous University of Mexico Mexico City, Mexico Alicia Huerta-Chagoya, Ph.D. Professor of Genetics, National Autonomous University of Mexico Researcher, National Institute of Medical Sciences and Nutrition Salvador Zubirán Mexico City, Mexico	COVID-19: a Global Health Perspective \| Mexico COVID-19 in Mexico and the impact of pre-existing conditions: Broad collaborators share perspectives on the global health impact of COVID-19 in Mexico.
Brought to you by the Broad Global Health Initiative and co-hosted with LatinX@Broad
Nancy Krieger Professor of Social Epidemiology and Director, Interdisciplinary Concentration on Women, Gender, and Health, Harvard T.H. Chan School of Public Health Adrianne Gladden-Young Senior Viral Genomics Researcher, Sabeti Lab at the Broad Institute, Author, "Give Black Scientists a Place in This Fight", The Atlantic Alister Martin Emergency Medical Specialist, Massachusetts General Hospital, MGH Center for Social Justice and Health Equity at Harvard Medical School	COVID-19: a Global Health Perspective \| Boston Area Health disparities impacting Black communities in the Boston area: Local academic, medical, and community leaders share data and perspectives on the racial disparities of the COVID-19 experience in the Boston area.
Brought to you by the Broad Global Health Initiative and co-hosted with Shades@Broad
Fernando Bozza, M.D., Ph.D. Senior Scientist, Oswaldo Cruz Foundation Head of Critical Care, National Institute of Infectious Diseases Rio de Janeiro, Brazil Socrates Herrera, M.D. Director, Caucaseco Scientific Research Center Cali, Colombia Marcia Castro, Ph.D. Andelot Professor of Demography, Chair, Department of Global Health and Population, Harvard T.H. Chan School of Public Health Boston, USA	COVID-19: a Global Health Perspective \| Brazil and Colombia (HD) Social, political, and public health factors fueling the COVID-19 crisis in South America: Friends and collaborators of Broad global health science, who are leading COVID-19 response efforts in their home countries, speak about the global health impact of COVID-19 in Brazil and Colombia.
Brought to you by the Broad Global Health Initiative and co-hosted with LatinX@Broad
Sun Jae Jung, M.D., Ph.D. Assistant Professor of Psychiatric Epidemiology, Yonsei University College of Medicine Seoul, South Korea Xiancang Ma, M.D. Professor of Psychiatry and Vice President, The First Affiliated Hospital of Xi’an Jiaotong University Xi’an, China	COVID-19: a Global Health Perspective \| China and South Korea Perspectives on the global health impact of COVID-19 and finding a “new normal” in South Korea and China: Partners from Broad’s Stanley Global efforts speak about tackling COVID-19 on the frontlines, the mental health burden of the pandemic in their communities, and lessons we can learn from their experience in the post-peak period.
Brought to you by the Broad Global Health Initiative
Dyann F. Wirth, Ph.D. Chair, World Health Organization Malaria Program Action Committee, Richard Pearson Strong Professor and Chair, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Faculty Chair, Harvard Integrated Life Sciences Program, Harvard Graduate School of Arts and Sciences Senior Associate Member, Broad Institute of MIT and Harvard	COVID-19: a Global Health Perspective Pandemic’s effects on endemic infectious diseases, like malaria, and the use of chloroquine, formerly best known as a malaria drug: Dyann Wirth, a leader of the World Health Organization’s Malaria Program Advisory Committee, discusses how the WHO is addressing COVID-19 and its impact on the burden and control of endemic infectious diseases, chloroquine as a potential COVID-19 treatment, and the impact on its use and availability as a frontline malaria therapy.
Brought to you by the Broad Global Health Initiative